Cytokines

Cytokines

Leave your request for services (Custom chemistry, HTS, CADD, Integrated Drug Discovery, ADME, PK)

Email us

ChemDiv proposes high throughput screening (HTS) service

Cytokines research platform

  • 92 assays, 9 classes of cytokines are available

Interleukins, Interferons, TNF cytokines, TGF-β cytokines, Hematopoietic Cytokines, C Chemokines, CC Chemokines, CXC Chemokines and CX3C Chemokines

  • Multiplex and ELISA cell-based assays
  • Track record of 25+ years’ experience, expertise in all major therapeutic areas
  • Full discovery support of your projects

CADD, synthetic and medicinal chemistry, preclinical biology, animal studies, CMC and formulation

  • Screening of up to 1.6M compounds

Cherry-pickable collection

  • Support for compound selection

Custom selection and screening set preparation from 1.6M stock available compounds

More details on prices, time, or research specificity - please contact chemdiv@chemdiv.com


Cytokines, being a part of the immune system, are potential targets for drug development to treat cancer, autoimmune diseases, inflammatory diseases, etc. Antagonists of IL-1 (such as IL-1ra) inhibit both IL-1-associated tumor development and IL-1-associated autoimmune diseases development. There are also several examples of successful chemokine targeting: CXCR4 inhibitor, plerixafor, mobilizes hematopoietic stem cells, and CCR5 antagonist maraviroc is used for HIV treatment.

For cytokines studies ChemDiv offers a Multiplex cell-based assay. Key advantages of Multiplex are:

  • Magnetic microspheres of designated colors are covered with antibodies of defined binding specificities
  • Target cytokine proteins bind to the “capture” antibodies on the surface of the microspheres
  • Incubation with “detection” antibodies and reporter molecules allows to measure fluorescence and adsorption 
  • Microspheres are classified one by one in a flow cell via laser detection system
  • Multiplex cytokine assay technology allows to measure numerous analytes in a single sample

Figure 1. Multiplex assay principle

For the following lead characterization during the inhibitor development ELISA cell-based assays are used. The key points for ELISA are:

  • Numerous cytokines produced by cell serve as antigens for the studies 
  • The antigens are bound to the wells of a microplate
  • Specific to the antigen antibodies, then reporter antibodies and coloring agents are added to tag the molecule of interest
  • Change in color allows to indirectly measure the amount of cytokines

List of targets:

  • Interleukins

  • Interferons

  • TNF

  • TGF-β

  • Hematopoietic Cytokines

  • C Chemokines

  • CC Chemokines

  • CXC Chemokines

  • CX3C Chemokines

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept